Navigation Links
Dalton Pharma Services Adds Formulation Development Services
Date:9/21/2009

Dalton Pharma Services is pleased to announce the expansion of its pharmaceutical manufacturing services by adding Formulation Development to its list of integrated capabilities.

Toronto, Ontario (PRWEB) September 21, 2009 -- Dalton Pharma Services is pleased to announce the expansion of its pharmaceutical manufacturing services by adding Formulation Development to its list of integrated capabilities.

This newly created department is comprised of highly experienced and educated teams. Dalton’s analytical, process and formulation scientists are equipped with advanced technology and infrastructure to provide clients with the expertise required to move virtually all types of molecules from development to commercialization in various types of dosage forms. Dosage forms include: sterile and non-sterile liquids, solids, semi-solids and lyophilized formulations (small chemical molecules, proteins and peptides, monoclonal antibodies and high-potency actives).

“Dalton continues to be at the forefront of research, technology and innovation to accelerate our clients’ drug development programs. The addition of Formulation Services to our integrated pharmaceutical development capabilities allows us to offer complete drug development and manufacturing of novel pharmaceutical products. Our investment in state of the art capsule filling technology is one of many examples of how we respond to our clients’ needs. We have also expanded our Analytical Services to serve our formulation development experts and as a result now offer dissolution testing and particle size distribution testing in our FDA compliant, Health Canada approved analytical testing laboratories,” said Peter Pekos, President and CEO of Dalton Pharma Services.

About Dalton Pharma Services:
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton provides cGMP manufacturing of solid dosage forms and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton’s analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.

For further information contact:
Peter Pekos
President & CEO
Dalton Pharma Services
Tel: 416-661-2102
www.dalton.com

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2915514.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services
2. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
3. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
4. Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008
5. PartsSource President & CEO A. Ray Dalton Named Harvard School of Business Entrepreneur of the Year
6. PartsSource President & CEO A. Ray Dalton Wins Innovation in Business Award
7. Thomson Reuters Launches Thomson Pharma Partnering Forecast
8. With Economic Pain Contributing to Minor Strains and Sprains, King Pharmaceuticals(R), Inc. and RealAge.com Launch Effort to Educate Americans on Prevention and Treatment
9. Keryx Biopharmaceuticals, Inc. to Hold Investor/Analyst Day Tomorrow
10. KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)
11. DOR BioPharma Announces $9.4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dalton Pharma Services Adds Formulation Development Services
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 Story Highlights: ... models within the health care industry is causing providers ... , Deloitte offers a suite of solutions for ... impacting efficient cost optimization: labor resource analysis, revenue cycle ... facilitate better outcomes and better economics ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
Breaking Medicine Technology: